REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Csontosne es Tarsa Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: CSONTOSNE ES TARSA Gyogyszer-kiskereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Csontosne es Tarsa Bt. is an enterprise located in Hungary, with the main office in Papa. It operates in the Pharmacies and Drug Stores sector. It was incorporated on September 26, 2003. The total number of employees is currently 7 (2024). In 2023, the company reported a net sales revenue increase of 13.26%. Its’ total assets recorded a negative growth of 5.49%. Csontosne es Tarsa Bt.’s net profit margin decreased by 0.65% in 2023.

Headquarters
Jokai Mor utca 108.
Papa; Veszprem; Postal Code: 8500

Contact Details: Purchase the Csontosne es Tarsa Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Csontosne es Tarsa Bt. report to view the information.
Outstanding Shares:
Purchase the Csontosne es Tarsa Bt. report to view the information.
Registered Capital:
Purchase the Csontosne es Tarsa Bt. report to view the information.
Financial Auditors:
Purchase the Csontosne es Tarsa Bt. report to view the information.
Incorporation Date:
September 26, 2003
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Csontosne es Tarsa Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.26%▲
Total operating revenue
13.22%▲
Operating profit (EBIT)
8.69%▲
EBITDA
6.77%▲
Net Profit (Loss) for the Period
6.7%▲
Total assets
-5.49%▼
Total equity
-6.3%▼
Operating Profit Margin (ROS)
-0.48%▼
Net Profit Margin
-0.65%▼
Return on Equity (ROE)
2.76%▲
Quick Ratio
-2.16%▼
Cash Ratio
-1.36%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo